XML 40 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 27, 2012
Jun. 29, 2011
Cash flows from operating activities:    
Net income $ 10,466 $ 12,254
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 11,887 14,422
Operating (gains), losses and other charges, net (4,174) (948)
Amortization of deferred financing costs 503 662
Amortization of debt discount 137 284
Loss on early extinguishment of debt 8,152 1,984
Loss on change in the fair value of interest rate cap 41 0
Deferred income tax expense 6,349 34
Share-based compensation 1,666 2,149
Decrease (increase) in assets:    
Receivables 791 1,929
Inventories 471 393
Other current assets 5,697 39
Other assets (2,046) 182
Increase (decrease) in liabilities:    
Accounts payable (5,781) 137
Accrued salaries and vacations (361) 553
Accrued taxes (135) 79
Other accrued liabilities (4,917) (5,897)
Other noncurrent liabilities and deferred credits (2,518) (3,321)
Net cash flows provided by operating activities 26,228 24,935
Cash flows from investing activities:    
Purchase of property (4,279) (8,854)
Proceeds from disposition of property 12,929 3,893
Collections on notes receivable 1,490 450
Issuance of notes receivable (1,124) 0
Net cash flows provided by (used in) investing activities 9,016 (4,511)
Cash flows from financing activities:    
Net borrowings under new credit agreement 190,000 0
Long-term debt payments (207,407) (22,084)
Proceeds from exercise of stock options 649 4,621
Tax withholding on share-based payments (145) 0
Tax benefit of stock options exercised 58 0
Debt transaction costs (1,095) (795)
Deferred financing costs (1,809) (3,247)
Purchase of treasury stock (5,470) (14,280)
Net bank overdrafts (2,768) (776)
Net cash flows used in financing activities (27,987) (36,561)
Increase (decrease) in cash and cash equivalents 7,257 (16,137)
Cash and cash equivalents at beginning of period 13,740 29,074
Cash and cash equivalents at end of period $ 20,997 $ 12,937